Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000318773> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W2000318773 endingPage "e25" @default.
- W2000318773 startingPage "e25" @default.
- W2000318773 abstract "Stem cell therapy is one of the most promising therapeutic innovations to help restore cardiac structure and function after ischemic insults to the heart. However, phase I and II clinical trials with autologous “first-generation stem cells” have yielded inconsistent results in ischemic cardiomyopathy patients and have not produced the definitive evidence for their broad clinical application.Recently, new cell types such as cardiac stem cells (CSC) and new allogeneic sources have attracted the attention of researchers given their inherent biological, clinical and logistic advantages. Preclinical evidence and emerging clinical data show that exogenous CSC produce a range of protein-based factors that have a powerful cardioprotective effect in the ischemic myocardium, immunoregulatory properties that promote angiogenesis and reduce scar formation, and are able to activate endogenous CSC which multiply and differentiate into cardiomyocytes and microvasculature.Furthermore, allogeneic CSC can be produced in large quantities beforehand and can be administered “off-the-shelf” early during the acute phase of myocardial ischemia. The distinctive immunological behavior of allogeneic CSC and their interaction with the host immune system is supposed to produce immunomodulatory beneficial effects in the short-term, preventing long-term side-effects after their rejection. Preclinical studies have shown highly promising results with allogeneic CSC, and clinical trials are already ongoing.Finally, unraveling questions about the biology and physiology of CSC, the characterization of their secretome, the conduction of larger clinical trials with autologous CSC, the definitive evidence on the safety and efficacy of allogeneic CSC in humans and the possibility of repeated administrations or combinations with other cell types and soluble factors will pave the road for further developments with CSC, that will undoubtedly determine the future of cardiovascular regenerative medicine in human beings." @default.
- W2000318773 created "2016-06-24" @default.
- W2000318773 creator A5030470874 @default.
- W2000318773 creator A5067347864 @default.
- W2000318773 date "2012-04-01" @default.
- W2000318773 modified "2023-09-26" @default.
- W2000318773 title "Authors' reply to “The not so ‘ideal’ body weight–based dosing of Integrilin in obesity”" @default.
- W2000318773 cites W2113047415 @default.
- W2000318773 cites W2126694303 @default.
- W2000318773 doi "https://doi.org/10.1016/j.ahj.2012.01.033" @default.
- W2000318773 hasPublicationYear "2012" @default.
- W2000318773 type Work @default.
- W2000318773 sameAs 2000318773 @default.
- W2000318773 citedByCount "0" @default.
- W2000318773 crossrefType "journal-article" @default.
- W2000318773 hasAuthorship W2000318773A5030470874 @default.
- W2000318773 hasAuthorship W2000318773A5067347864 @default.
- W2000318773 hasConcept C10882517 @default.
- W2000318773 hasConcept C111566952 @default.
- W2000318773 hasConcept C126322002 @default.
- W2000318773 hasConcept C164705383 @default.
- W2000318773 hasConcept C203014093 @default.
- W2000318773 hasConcept C2775932942 @default.
- W2000318773 hasConcept C2778198053 @default.
- W2000318773 hasConcept C2778797674 @default.
- W2000318773 hasConcept C2780394083 @default.
- W2000318773 hasConcept C28328180 @default.
- W2000318773 hasConcept C2911091166 @default.
- W2000318773 hasConcept C502942594 @default.
- W2000318773 hasConcept C535046627 @default.
- W2000318773 hasConcept C541997718 @default.
- W2000318773 hasConcept C71924100 @default.
- W2000318773 hasConcept C78085059 @default.
- W2000318773 hasConcept C86803240 @default.
- W2000318773 hasConcept C8891405 @default.
- W2000318773 hasConcept C95444343 @default.
- W2000318773 hasConceptScore W2000318773C10882517 @default.
- W2000318773 hasConceptScore W2000318773C111566952 @default.
- W2000318773 hasConceptScore W2000318773C126322002 @default.
- W2000318773 hasConceptScore W2000318773C164705383 @default.
- W2000318773 hasConceptScore W2000318773C203014093 @default.
- W2000318773 hasConceptScore W2000318773C2775932942 @default.
- W2000318773 hasConceptScore W2000318773C2778198053 @default.
- W2000318773 hasConceptScore W2000318773C2778797674 @default.
- W2000318773 hasConceptScore W2000318773C2780394083 @default.
- W2000318773 hasConceptScore W2000318773C28328180 @default.
- W2000318773 hasConceptScore W2000318773C2911091166 @default.
- W2000318773 hasConceptScore W2000318773C502942594 @default.
- W2000318773 hasConceptScore W2000318773C535046627 @default.
- W2000318773 hasConceptScore W2000318773C541997718 @default.
- W2000318773 hasConceptScore W2000318773C71924100 @default.
- W2000318773 hasConceptScore W2000318773C78085059 @default.
- W2000318773 hasConceptScore W2000318773C86803240 @default.
- W2000318773 hasConceptScore W2000318773C8891405 @default.
- W2000318773 hasConceptScore W2000318773C95444343 @default.
- W2000318773 hasIssue "4" @default.
- W2000318773 hasLocation W20003187731 @default.
- W2000318773 hasOpenAccess W2000318773 @default.
- W2000318773 hasPrimaryLocation W20003187731 @default.
- W2000318773 hasRelatedWork W1833965004 @default.
- W2000318773 hasRelatedWork W1966569956 @default.
- W2000318773 hasRelatedWork W1974597877 @default.
- W2000318773 hasRelatedWork W1994785865 @default.
- W2000318773 hasRelatedWork W2054784483 @default.
- W2000318773 hasRelatedWork W2412929569 @default.
- W2000318773 hasRelatedWork W2883585499 @default.
- W2000318773 hasRelatedWork W2949332061 @default.
- W2000318773 hasRelatedWork W4315436716 @default.
- W2000318773 hasRelatedWork W92686711 @default.
- W2000318773 hasVolume "163" @default.
- W2000318773 isParatext "false" @default.
- W2000318773 isRetracted "false" @default.
- W2000318773 magId "2000318773" @default.
- W2000318773 workType "article" @default.